ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1794

Characteristics of Patients with Repeat Visits for Acute Gout at a University Hospital Emergency Department

David Lim1, Manushi Aggarwal1 and Marven Cabling2, 1Loma Linda University Health, Redlands, CA, 2Loma Linda University, REDLANDS, CA

Meeting: ACR Convergence 2022

Keywords: gout, Nonsteroidal antiinflammatory drugs (NSAIDs), Uric Acid, Urate

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: Metabolic and Crystal Arthropathies – Basic and Clinical Science Poster

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: Gout is the most common inflammatory arthritis in adults that results in high disease burden and health care utilization. The objective of the study is to describe factors seen in patients with repeat Emergency Department (ED) visits at a university hospital to elucidate barriers in gout care and improve health care utilization.

Methods: A retrospective chart review of adult patients seen at a university hospital ED with a discharge diagnosis of gout from 1/1/2019 to 12/31/2020 was performed. Patient demographics, comorbidities, outpatient drugs, diagnostic and therapeutic interventions performed at the ED were noted. The admitting diagnoses of patients who required hospitalization were evaluated. Descriptive statistics and Pearson’s chi-square test were performed between those that had repeat ED visits and those with a single ED visit.

Results: A total of 115 patients were included: 28 patients (24.3%) had repeat ED visits, while 87 patients (75.7%) had a single visit (Table 1). Most patients were elderly, male, obese, and did not have prior intake of urate lowering therapy (ULT) and/or anti-inflammatory drugs (AID). A higher proportion of Asian patients returned to the ED, while Hispanics were less likely to return. Patients with Medicare insurance and comorbidities, including hypertension (71.4%) and hyperlipidemia (50%) were more often seen in the ED return group. Most patients with repeat ED visits already had a documented history of clinically diagnosed gout, with most having no history of prior aspiration for crystal diagnosis. Outpatient management by primary care physician and not having an outpatient visit within the preceding 12 months was more common in those with repeat ED visits.

Time of ED presentation was similar between the two groups, as was getting labs obtained (Table 2). Outpatient uric acid levels were similarly not at goal. Those that returned to the ED had a mean creatinine that was within normal limits, while those with a single ED visit had a higher average creatinine. Overall, arthrocentesis was seldom performed at the ED (14.8%), and when performed, urate crystals were identified 64.7% of the time. ULT management in the ED and use of consultation services were similarly low. Only 4.3% of the total patients were started on ULT at the ED. Most were given a NSAID for pain.

Hospitalizations were highest in the group with a single ED visit (20.7%) while only 1 patient was admitted in the group with repeat ED visits. Among those that had an inpatient admission, most were for reasons other than acute gout (Table 3).

Conclusion: Our findings show that certain factors are seen more frequently in patients with repeat ED visits for gout. Asian ethnicity, the presence of comorbidities, and not having outpatient follow up were more frequently seen in those with repeat ED visits. While arthrocentesis is the gold standard for gout diagnosis, this is rarely performed. There was less ED return in patients who had an inpatient admission, although a majority of admitting diagnoses were for reasons other than acute gout. Further studies analyzing characteristics of gout patients associated with recurrent ED visits and hospitalizations are needed to improve outcomes.

Supporting image 1

Table 1. Patient Characteristics

Supporting image 2

Table 2. Emergency Department Presentation/Laboratory Data

Supporting image 3

Table 3. Discharge Diagnosis of Patients Admitted for Hospitalization


Disclosures: D. Lim, None; M. Aggarwal, None; M. Cabling, None.

To cite this abstract in AMA style:

Lim D, Aggarwal M, Cabling M. Characteristics of Patients with Repeat Visits for Acute Gout at a University Hospital Emergency Department [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/characteristics-of-patients-with-repeat-visits-for-acute-gout-at-a-university-hospital-emergency-department/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characteristics-of-patients-with-repeat-visits-for-acute-gout-at-a-university-hospital-emergency-department/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology